The pharmaceutical industry is experiencing a seismic shift in customer engagement, driven by increasing demands for digital-first, personalized experiences. From patients seeking on-demand care to healthcare providers requiring streamlined information access, traditional pharma marketing approaches are being revolutionized by AI capabilities. Industry leaders are reimagining how they connect with their audiences through AI-powered solutions.
Amy Turnquist, Life Sciences AVP at North Highland, recently attended two industry roundtables facilitated by MM+M. The discussions focused on how pharma companies are using AI, from personalization and customer experience to sales force enablement and direct-to-consumer (DTC) models.
What to look for:
- Moving beyond segmentation to adapt in real-time to customer behaviors
- First-party data strategies to deliver personalized experiences at scale
- Evolving current "next-best action" models to optimize engagement
- Virtual assistants to streamline access to critical medical information
Read the full articles to discover how pharma leaders are balancing innovation with trust in the AI era:
Featuring
Amy Turnquist